FDA.reportPublic FDA data

Lampit 30 MG Oral Tablet

RxCUI
2397991
RxNorm name
Lampit 30 MG Oral Tablet
Display name
Lampit 30 MG Oral Tablet
Full name
Lampit 30 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LAMPITNIFURTIMOXBayer HealthCare Pharmaceuticals Inc.90d09714-a8b1-4696-8ada-f99dc54d07212026-03-03Warnings, Adverse reactionsExact identifier
rxcui: 2397991

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
90d09714-a8b1-4696-8ada-f99dc54d0721Lampit 30 MG Oral Tablet [PSN] · nifurtimox 30 MG Oral Tablet [Lampit] [SBD] · Lampit 30 MG Oral Tablet [SY]39These highlights do not include all the information needed to use LAMPIT safely and effectively. See full prescribing information for LAMPIT. LAMPIT (nifurtimox) tablets, for oral use Initial U.S. Approval: 202020260303